BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessCURE Pharmaceutical Receives First Purchase Order Stemming from Product Development and License Agreement with Pharmaceutical Company, Meroven LTD.By Nasdaq OMXMay 24, 2017, 1:11 PM UTC
BusinessAXIM Biotech to Present Research Abstracts at the 6th Pharmaceutical Sciences World CongressBy Nasdaq OMXMay 23, 2017, 1:06 PM UTC
BusinessAXIM Biotech to Present Research Abstracts at the 6th Pharmaceutical Sciences World CongressBy Nasdaq OMXMay 23, 2017, 1:06 PM UTC